The binding of mAb CC4 to bladder cancer T2-4 cells transfected with CEACAM5-expressing vectors further validated the recognition of mAb CC4 to CEACAM5 (Figure 1G). The gene discussed is CEACAM5; the disease is urinary bladder cancer.